Surgical Hemostatic Articles & Analysis
5 news found
Endomedix, Inc. announced today that it has entered into a Cooperative Research and Development Agreement or CRADA with the US. Army Institute of Surgical Research (USAISR) and the U.S. Army Medical Materiel Development Activity (USAMMDA). ...
Endomedix is planning a series of follow-on technical articles to describe the biomaterials produced with its methods and materials, as well as in vivo trial results of prototypes for its first device, a spray-on absorbable hemostat intended for use in brain and spine surgery. About Endomedix, Inc. ...
The poster will feature the biopolymer technology’s 5 complementary mechanisms of action that lead to fast hemostasis of heavy bleeds. 4 of the 5 complementary mechanisms are unique and the subject of the company’s latest patent applications. Unlike currently available hemostats that require continuous manual pressure to be effective, the Endomedix device can spray ...
Additionally, the presentation will provide information on the consolidation or shrinkage of its hemostatic material when placed in moist or wet environments. Currently available hemostats generally swell when placed into such environments. ...
The National Institute for Neurological Disorders and Stroke is currently funding the Endomedix program to develop a surgical hemostat indicated for use in intracranial surgery through a multi-year Phase II SBIR grant. ...